Correction to: The Pharmacogenomics Journal (2016) 16, 566–572; doi:10.1038/tpj.2015.76; published online 27 October 2015
In the originally published version of this paper, the author affiliations were incorrect. The correct affiliations appear below. The publisher regrets the error.
TM Dodgen1,2, C De J Labuschagne3, A van Schalkwyk3, FE Steffens4, A Gaedigk5, AD Cromarty1, M Alessandrini2 and MS Pepper2,6
1Department of Pharmacology, University of Pretoria, Pretoria, South Africa;
2Department of Immunology and Institute for Cellular and Molecular Medicine, University of Pretoria, Pretoria, South Africa;
3Inqaba Biotechnical Industries, Pretoria, South Africa;
4Department of Consumer Science, University of Pretoria, Pretoria, South Africa;
5Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children’s Mercy Kansas City, and School of Medicine, University of Missouri-Kansas City, Kansas City, MO, USA;
6Department of Genetic Medicine and Development, University of Geneva, Geneva, Switzerland.
Additional information
The online version of the original article can be found at 10.1038/tpj.2015.76
Rights and permissions
About this article
Cite this article
Dodgen, T., De J Labuschagne, C., van Schalkwyk, A. et al. Erratum: Pharmacogenetic comparison of CYP2D6 predictive and measured phenotypes in a South African cohort. Pharmacogenomics J 17, 393 (2017). https://doi.org/10.1038/tpj.2017.20
Published:
Issue Date:
DOI: https://doi.org/10.1038/tpj.2017.20
